Vitamin D affects antiphospholipid syndrome by regulating T cells (Review)
- Authors:
- Rongxiu Huo
- Yanting Yang
- Chengcheng Wei
- Xiaocong Huo
- Danli Meng
- Yang Yang
- Yijia Huang
- Rongjun Huang
- Jinying Lin
- Xinxiang Huang
-
Affiliations: Department of Rheumatology and Immunology, Guangxi Academy of Medical Sciences, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Zhuang Autonomous Region 530016, P.R. China - Published online on: December 12, 2024 https://doi.org/10.3892/ijmm.2024.5471
- Article Number: 30
-
Copyright: © Huo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Płudowski P, Kos-Kudła B, Walczak M, Fal A, Zozulińska-Ziółkiewicz D, Sieroszewski P, Peregud-Pogorzelski J, Lauterbach R, Targowski T, Lewiński A, et al: Guidelines for preventing and treating vitamin D deficiency: A 2023 update in Poland. Nutrients. 15:6952023. View Article : Google Scholar : | |
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, et al: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 4:295–306. 2006. View Article : Google Scholar : PubMed/NCBI | |
Sciascia S, Amigo MC, Roccatello D and Khamashta M: Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances. Nat Rev Rheumatol. 13:548–560. 2017. View Article : Google Scholar : PubMed/NCBI | |
Sciascia S, Sanna G, Murru V, Roccatello D, Khamashta MA and Bertolaccini ML: Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review. Thromb Haemost. 111:354–364. 2014. View Article : Google Scholar | |
Kravvariti E, Konstantonis G, Tentolouris N, Sfikakis PP and Tektonidou MG: Carotid and femoral atherosclerosis in antiphospholipid syndrome: Equivalent risk with diabetes mellitus in a case-control study. Semin Arthritis Rheum. 47:883–889. 2018. View Article : Google Scholar | |
Tektonidou MG, Vlachogiannis NI and Sfikakis PP: T cell involvement in antiphospholipid syndrome. Clin Immunol. 263:1102182024. View Article : Google Scholar : PubMed/NCBI | |
Della Nera G, Sabatino L, Gaggini M, Gorini F and Vassalle C: Vitamin D determinants, status, and antioxidant/anti-inflammatory-related effects in cardiovascular risk and disease: Not the last word in the controversy. Antioxidants (Basel). 12:9482023. View Article : Google Scholar : PubMed/NCBI | |
Aggeletopoulou I, Marangos M, Assimakopoulos SF, Mouzaki A, Thomopoulos K and Triantos C: Vitamin D and microbiome: molecular interaction in inflammatory bowel disease pathogenesis. Am J Pathol. 193:656–668. 2023. View Article : Google Scholar : PubMed/NCBI | |
Muñoz A and Grant WB: Vitamin D and cancer: An historical overview of the epidemiology and mechanisms. Nutrients. 14:14482022. View Article : Google Scholar : PubMed/NCBI | |
Carlberg C and Muñoz A: An update on vitamin D signaling and cancer. Semin Cancer Biol. 79:217–230. 2022. View Article : Google Scholar | |
Ao T, Kikuta J and Ishii M: The effects of vitamin D on immune system and inflammatory diseases. Biomolecules. 11:16242021. View Article : Google Scholar : PubMed/NCBI | |
Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF and O'Garra A: 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol. 167:4974–4980. 2001. View Article : Google Scholar : PubMed/NCBI | |
Zhao H, Wei X and Yang X: A novel update on vitamin D in recurrent pregnancy loss (Review). Mol Med Rep. 23:3822021. View Article : Google Scholar | |
Sayar Z, Moll R, Isenberg D and Cohen H: Thrombotic antiphospholipid syndrome: A practical guide to diagnosis and management. Thromb Res. 198:213–221. 2021. View Article : Google Scholar : PubMed/NCBI | |
Shah R, Mohammed YN, Koehler TJ, Kaur J, Toufeili M, Pulipati P, Alqaysi A, Khan A, Khalid M, Lee Y, et al: Antiphospholipid antibodies and vitamin D deficiency in COVID-19 infection with and without venous or arterial thrombosis: A pilot case-control study. PLoS One. 17:e02694662022. View Article : Google Scholar : PubMed/NCBI | |
Zhang H, Ding X, Hu X, Cai YX, Chen H, Sun C, Chen J, Li X, Zheng Z, Liao T, et al: Associations between 25 hydroxyvitamin D concentration and spontaneous abortion. BMC Public Health. 24:18582024. View Article : Google Scholar : PubMed/NCBI | |
Chen C, Wang S, Zhang C, Wu X, Zhou L, Zou X, Guan T, Zhang Z and Hao J: Association between serum vitamin D level during pregnancy and recurrent spontaneous abortion: A systematic review and meta-analysis. Am J Reprod Immunol. 88:e135822022. View Article : Google Scholar : PubMed/NCBI | |
Duarte-García A, Pham MM, Crowson CS, Amin S, Moder KG, Pruthi RK, Warrington KJ and Matteson EL: The epidemiology of antiphospholipid syndrome: A population-based study. Arthritis Rheumatol. 71:1545–1552. 2019. View Article : Google Scholar : PubMed/NCBI | |
Petri M: Antiphospholipid syndrome. Transl Res. 225:70–81. 2020. View Article : Google Scholar : PubMed/NCBI | |
Cashman KD, Dowling KG, Škrabáková Z, Gonzalez-Gross M, Valtueña J, De Henauw S, Moreno L, Damsgaard CT, Michaelsen KF, Mølgaard C, et al: Vitamin D deficiency in Europe: Pandemic? Am J Clin Nutr. 103:1033–1044. 2016. View Article : Google Scholar : PubMed/NCBI | |
Cashman KD: Vitamin D deficiency: defining, prevalence, causes, and strategies of addressing. Calcif Tissue Int. 106:14–29. 2020. View Article : Google Scholar | |
Sarafin K, Durazo-Arvizu R, Tian L, Phinney KW, Tai S, Camara JE, Merkel J, Green E, Sempos CT and Brooks SP: Standardizing 25-hydroxyvitamin D values from the Canadian health measures survey. Am J Clin Nutr. 102:1044–1050. 2015. View Article : Google Scholar : PubMed/NCBI | |
Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Köstenberger M, Tmava Berisha A, Martucci G, Pilz S and Malle O: Vitamin D deficiency 2.0: An update on the current status worldwide. Eur J Clin Nutr. 74:1498–1513. 2020. View Article : Google Scholar : PubMed/NCBI | |
Md Isa Z, Mohd Nordin NR, Mahmud MH and Hashim S: An Update on vitamin D deficiency status in Malaysia. Nutrients. 14:5672022. View Article : Google Scholar : PubMed/NCBI | |
Islam MA, Ahmed S, Sultana S, Alam SS, Hossan T, Gouda W, Alsaqabi F, Hassan R and Kotyla PJ: Vitamin D status in patients with primary antiphospholipid syndrome (PAPS): A systematic review and meta-analysis. Antibodies (Basel). 13:222024. View Article : Google Scholar : PubMed/NCBI | |
Fernando M, Ellery SJ, Marquina C, Lim S, Naderpoor N and Mousa A: Vitamin D-binding protein in pregnancy and reproductive health. Nutrients. 12:14892020. View Article : Google Scholar : PubMed/NCBI | |
Jäpelt RB and Jakobsen J: Vitamin D in plants: A review of occurrence, analysis, and biosynthesis. Front Plant Sci. 4:1362013. View Article : Google Scholar : PubMed/NCBI | |
Tsuprykov O, Chen X, Hocher CF, Skoblo R, Yin L and Hocher B: Why should we measure free 25(OH) vitamin D? J Steroid Biochem Mol Biol. 180:87–104. 2018. View Article : Google Scholar | |
Al-Ishaq RK, Kubatka P, Brozmanova M, Gazdikova K, Caprnda M and Büsselberg D: Health implication of vitamin D on the cardiovascular and the renal system. Arch Physiol Biochem. 127:195–209. 2021. View Article : Google Scholar | |
Keane JT, Elangovan H, Stokes RA and Gunton JE: Vitamin D and the liver-correlation or cause? Nutrients. 10:4962018. View Article : Google Scholar : PubMed/NCBI | |
de Paula FJA and Rosen CJ: Vitamin D safety and requirements. Arch Biochem Biophys. 523:64–72. 2012. View Article : Google Scholar : | |
Zmijewski MA and Carlberg C: Vitamin D receptor(s): In the nucleus but also at membranes? Exp Dermatol. 29:876–884. 2020. View Article : Google Scholar : PubMed/NCBI | |
Arora J, Wang J, Weaver V, Zhang Y and Cantorna MT: Novel insight into the role of the vitamin D receptor in the development and function of the immune system. J Steroid Biochem Mol Biol. 219:1060842022. View Article : Google Scholar : PubMed/NCBI | |
Khundmiri SJ, Murray RD and Lederer E: PTH and vitamin D. Compr Physiol. 6:561–601. 2016. View Article : Google Scholar : PubMed/NCBI | |
Li YC, Chen Y and Du J: Critical roles of intestinal epithelial vitamin D receptor signaling in controlling gut mucosal inflammation. J Steroid Biochem Mol Biol. 148:179–183. 2015. View Article : Google Scholar : PubMed/NCBI | |
Mohammad S, Mishra A and Ashraf MZ: Emerging role of vitamin D and its associated molecules in pathways related to pathogenesis of thrombosis. Biomolecules. 9:6492019. View Article : Google Scholar : PubMed/NCBI | |
Battault S, Whiting SJ, Peltier SL, Sadrin S, Gerber G and Maixent JM: Vitamin D metabolism, functions and needs: From science to health claims. Eur J Nutr. 52:429–441. 2013. View Article : Google Scholar | |
Hewison M, Freeman L, Hughes SV, Evans KN, Bland R, Eliopoulos AG, Kilby MD, Moss PA and Chakraverty R: Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol. 170:5382–5390. 2003. View Article : Google Scholar : PubMed/NCBI | |
Fritsche J, Mondal K, Ehrnsperger A, Andreesen R and Kreutz M: Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells. Blood. 102:3314–3316. 2003. View Article : Google Scholar : PubMed/NCBI | |
Harrison SR, Li D, Jeffery LE, Raza K and Hewison M: Vitamin D, autoimmune disease and rheumatoid arthritis. Calcif Tissue Int. 106:58–75. 2020. View Article : Google Scholar : | |
Hewison M, Zehnder D, Chakraverty R and Adams JS: Vitamin D and barrier function: A novel role for extra-renal 1 alpha-hydroxylase. Mol Cell Endocrinol. 215:31–38. 2004. View Article : Google Scholar : PubMed/NCBI | |
Penna G and Adorini L: 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol. 164:2405–2411. 2000. View Article : Google Scholar : PubMed/NCBI | |
Bartels LE, Jørgensen SP, Agnholt J, Kelsen J, Hvas CL and Dahlerup JF: 1,25-dihydroxyvitamin D3 and dexamethasone increase interleukin-10 production in CD4+ T cells from patients with Crohn's disease. Int Immunopharmacol. 7:1755–1764. 2007. View Article : Google Scholar : PubMed/NCBI | |
Széles L, Keresztes G, Töröcsik D, Balajthy Z, Krenács L, Póliska S, Steinmeyer A, Zuegel U, Pruenster M, Rot A and Nagy L: 1,25-dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype. J Immunol. 182:2074–2083. 2009. View Article : Google Scholar : PubMed/NCBI | |
Piemonti L, Monti P, Sironi M, Fraticelli P, Leone BE, Dal Cin E, Allavena P and Di Carlo V: Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol. 164:4443–4451. 2000. View Article : Google Scholar : PubMed/NCBI | |
Hewison M: Vitamin D and immune function: An overview. Proc Nutr Soc. 71:50–61. 2012. View Article : Google Scholar | |
Cantorna MT, Snyder L, Lin YD and Yang L: Vitamin D and 1,25(OH)2D regulation of T cells. Nutrients. 7:3011–3021. 2015. View Article : Google Scholar : PubMed/NCBI | |
Cippitelli M, Fionda C, Di Bona D, Di Rosa F, Lupo A, Piccoli M, Frati L and Santoni A: Negative regulation of CD95 ligand gene expression by vitamin D3 in T lymphocytes. J Immunol. 168:1154–1166. 2002. View Article : Google Scholar : PubMed/NCBI | |
Xie Z, Chen J, Zheng C, Wu J, Cheng Y, Zhu S, Lin C, Cao Q, Zhu J and Jin T: 1,25-dihydroxyvitamin D3-induced dendritic cells suppress experimental autoimmune encephalomyelitis by increasing proportions of the regulatory lymphocytes and reducing T helper type 1 and type 17 cells. Immunology. 152:414–424. 2017. View Article : Google Scholar : PubMed/NCBI | |
Bellan M, Andreoli L, Mele C, Sainaghi PP, Rigamonti C, Piantoni S, De Benedittis C, Aimaretti G, Pirisi M and Marzullo P: Pathophysiological role and therapeutic implications of vitamin D in autoimmunity: Focus on chronic autoimmune diseases. Nutrients. 12:7892020. View Article : Google Scholar : PubMed/NCBI | |
Zhou Q, Qin S, Zhang J, Zhon L, Pen Z and Xing T: 1,25(OH)2D3 induces regulatory T cell differentiation by influencing the VDR/PLC-γ1/TGF-β1/pathway. Mol Immunol. 91:156–164. 2017. View Article : Google Scholar : PubMed/NCBI | |
Germain SJ, Sacks GP, Sooranna SR, Sargent IL and Redman CW: Systemic inflammatory priming in normal pregnancy and preeclampsia: The role of circulating syncytiotrophoblast microparticles. J Immunol. 178:5949–5956. 2007. View Article : Google Scholar : PubMed/NCBI | |
Torchinsky A, Shepshelovich J, Orenstein H, Zaslavsky Z, Savion S, Carp H, Fain A and Toder V: TNF-alpha protects embryos exposed to developmental toxicants. Am J Reprod Immunol. 49:159–168. 2003. View Article : Google Scholar : PubMed/NCBI | |
Piccinni MP, Raghupathy R, Saito S and Szekeres-Bartho J: Cytokines, hormones and cellular regulatory mechanisms favoring successful reproduction. Front Immunol. 12:7178082021. View Article : Google Scholar : PubMed/NCBI | |
Casazza RL, Lazear HM and Miner JJ: Protective and pathogenic effects of interferon signaling during pregnancy. Viral Immunol. 33:3–11. 2020. View Article : Google Scholar : | |
Yang X, Tian Y, Zheng L, Luu T and Kwak-Kim J: The update immune-regulatory role of pro- and anti-inflammatory cytokines in recurrent pregnancy losses. Int J Mol Sci. 24:1322022. View Article : Google Scholar | |
Michimata T, Tsuda H, Sakai M, Fujimura M, Nagata K, Nakamura M and Saito S: Accumulation of CRTH2-positive T-helper 2 and T-cytotoxic 2 cells at implantation sites of human decidua in a prostaglandin D(2)-mediated manner. Mol Hum Reprod. 8:181–187. 2002. View Article : Google Scholar | |
Mitchell RE, Hassan M, Burton BR, Britton G, Hill EV, Verhagen J and Wraith DC: IL-4 enhances IL-10 production in Th1 cells: Implications for Th1 and Th2 regulation. Sci Rep. 7:113152017. View Article : Google Scholar : PubMed/NCBI | |
Nakashima A, Ito M, Yoneda S, Shiozaki A, Hidaka T and Saito S: Circulating and decidual Th17 cell levels in healthy pregnancy. Am J Reprod Immunol. 63:104–109. 2010. View Article : Google Scholar | |
Cua DJ and Tato CM: Innate IL-17-producing cells: The sentinels of the immune system. Nat Rev Immunol. 10:479–489. 2010. View Article : Google Scholar : PubMed/NCBI | |
Cyprian F, Lef kou E, Varoudi K and Girardi G: Immunomodulatory effects of vitamin D in pregnancy and beyond. Front Immunol. 10:27392019. View Article : Google Scholar : PubMed/NCBI | |
Minton K: Vitamin D shuts down T cell-mediated inflammation. Nat Rev Immunol. 22:12022. View Article : Google Scholar | |
Zhang H, Wang S, Tuo L, Zhai Q, Cui J, Chen D and Xu D: Relationship between maternal vitamin D levels and adverse outcomes. Nutrients. 14:42302022. View Article : Google Scholar : PubMed/NCBI | |
Schröder-Heurich B, Springer CJP and von Versen-Höynck F: Vitamin D effects on the immune system from periconception through pregnancy. Nutrients. 12:14322020. View Article : Google Scholar : PubMed/NCBI | |
Renaud SJ, Postovit LM, Macdonald-Goodfellow SK, McDonald GT, Caldwell JD and Graham CH: Activated macrophages inhibit human cytotrophoblast invasiveness in vitro. Biol Reprod. 73:237–243. 2005. View Article : Google Scholar : PubMed/NCBI | |
Seki H, Matuoka K, Inooku H and Takeda S: TNF-alpha from monocyte of patients with pre-eclampsia-induced apoptosis in human trophoblast cell line. J Obstet Gynaecol Res. 33:408–416. 2007. View Article : Google Scholar : PubMed/NCBI | |
Lockwood CJ, Oner C, Uz YH, Kayisli UA, Huang SJ, Buchwalder LF, Murk W, Funai EF and Schatz F: Matrix metalloproteinase 9 (MMP9) expression in preeclamptic decidua and MMP9 induction by tumor necrosis factor alpha and interleukin 1 beta in human first trimester decidual cells. Biol Reprod. 78:1064–1072. 2008. View Article : Google Scholar : PubMed/NCBI | |
Raphael I, Nalawade S, Eagar TN and Forsthuber TG: T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine. 74:5–17. 2015. View Article : Google Scholar : | |
Jara LJ, Medina G, Cruz-Dominguez P, Navarro C, Vera-Lastra O and Saavedra MA: Risk factors of systemic lupus erythematosus flares during pregnancy. Immunol Res. 60:184–192. 2014. View Article : Google Scholar : PubMed/NCBI | |
Travis OK, White D, Pierce WA, Ge Y, Stubbs CY, Spradley FT, Williams JM and Cornelius DC: Chronic infusion of interleukin-17 promotes hypertension, activation of cytolytic natural killer cells, and vascular dysfunction in pregnant rats. Physiol Rep. 7:e140382019. View Article : Google Scholar : PubMed/NCBI | |
Idali F, Rezaii-Nia S, Golshahi H, Fatemi R, Naderi MM, Goli LB, Zarnani AH and Jeddi-Tehrani M: Adoptive cell therapy with induced regulatory T cells normalises the abortion rate in abortion-prone mice. Reprod Fertil Dev. 33:220–228. 2021. | |
Benagiano M, Borghi MO, Romagnoli J, Mahler M, Bella CD, Grassi A, Capitani N, Emmi G, Troilo A, Silvestri E, et al: Interleukin-17/Interleukin-21 and interferon-γ producing T cells specific for β2 glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome. Haematologica. 104:2519–2527. 2019. View Article : Google Scholar : PubMed/NCBI | |
Robert M, Miossec P and Hot A: The Th17 pathway in vascular inflammation: Culprit or consort? Front Immunol. 13:8887632022. View Article : Google Scholar : PubMed/NCBI | |
Cremoni M, Brglez V, Perez S, Decoupigny F, Zorzi K, Andreani M, Gérard A, Boyer-Suavet S, Ruetsch C, Benzaken S, et al: Th17-immune response in patients with membranous nephropathy is associated with thrombosis and relapses. Front Immunol. 11:5749972020. View Article : Google Scholar : PubMed/NCBI | |
Rawal N and Pangburn MK: Formation of high affinity C5 convertase of the classical pathway of complement. J Biol Chem. 278:38476–38483. 2003. View Article : Google Scholar : PubMed/NCBI | |
Liu X, Hu Y, Yu X, Tan Y, Yu F, Chen M and Zhao M: Differential contributions of the C5b-9 and C5a/C5aR pathways to microvascular and macrovascular thrombosis in complement-mediated thrombotic microangiopathy patients. Clin Immunol. 259:1098712024. View Article : Google Scholar | |
Li H, Xie X, Bai G, Qiang D, Zhang L, Liu H, He Y, Tang Y and Li L: Vitamin D deficiency leads to the abnormal activation of the complement system. Immunol Res. 71:29–38. 2023. View Article : Google Scholar : | |
Skendros P, Mitsios A, Chrysanthopoulou A, Mastellos DC, Metallidis S, Rafailidis P, Ntinopoulou M, Sertaridou E, Tsironidou V, Tsigalou C, et al: Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J Clin Invest. 130:6151–6157. 2020. View Article : Google Scholar : PubMed/NCBI | |
Chen Y, Li X, Lin X, Liang H, Liu X, Zhang X, Zhang Q, Zhou F, Yu C, Lei L and Xiu J: Complement C5a induces the generation of neutrophil extracellular traps by inhibiting mitochondrial STAT3 to promote the development of arterial thrombosis. Thromb J. 20:242022. View Article : Google Scholar : PubMed/NCBI | |
Borghi MO, Raschi E, Grossi C, Chighizola CB and Meroni PL: Toll-like receptor 4 and β2 glycoprotein I interaction on endothelial cells. Lupus. 23:1302–1304. 2014. View Article : Google Scholar : PubMed/NCBI | |
Matias ML, Romao-Veiga M, Ribeiro VR, Nunes PR, Gomes VJ, Devides AC, Borges VT, Romagnoli GG, Peracoli JC and Peracoli MT: Progesterone and vitamin D downregulate the activation of the NLRP1/NLRP3 inflammasomes and TLR4-MyD88-NF-κB pathway in monocytes from pregnant women with preeclampsia. J Reprod Immunol. 144:1032862021. View Article : Google Scholar | |
Martinez-Moreno JM, Herencia C, Montes de Oca A, Muñoz-Castañeda JR, Rodríguez-Ortiz ME, Díaz-Tocados JM, Peralbo-Santaella E, Camargo A, Canalejo A, Rodriguez M, et al: Vitamin D modulates tissue factor and protease-activated receptor 2 expression in vascular smooth muscle cells. FASEB J. 30:1367–1376. 2016. View Article : Google Scholar | |
Chen SF: 1 alpha, 25-Dihydroxyvitamin D3 decreased ICAM-1 and ELAM-1 expressions on pulmonary microvascular endothelial cells and neutrophil motivation. J Steroid Biochem Mol Biol. 52:67–70. 1995. View Article : Google Scholar : PubMed/NCBI | |
Jamali N, Song YS, Sorenson CM and Sheibani N: 1,25(OH)2D3 regulates the proangiogenic activity of pericyte through VDR-mediated modulation of VEGF production and signaling of VEGF and PDGF receptors. FASEB Bioadv. 1:415–434. 2019. View Article : Google Scholar : PubMed/NCBI | |
Aihara K, Azuma H and Matsumoto T: Vitamin D-vitamin D receptor system regulates antithrombogenicity in vivo. Clin Calcium. 16:1173–1179. 2006.In Japanese. PubMed/NCBI | |
Han T, Liu M and Yang S: DJ-1 alleviates angiotensin II-induced endothelial progenitor cell damage by activating the PPARγ/HO-1 pathway. J Cell Biochem. 119:392–400. 2018. View Article : Google Scholar | |
Haseda F, Imagawa A, Murase-Mishiba Y, Terasaki J and Hanafusa T: CD4+ CD45RA− FoxP3high activated regulatory T cells are functionally impaired and related to residual insulin-secreting capacity in patients with type 1 diabetes. Clin Exp Immunol. 173:207–216. 2013. View Article : Google Scholar : PubMed/NCBI | |
He LP, Song YX, Zhu T, Gu W and Liu CW: Progress in the relationship between vitamin D deficiency and the incidence of type 1 diabetes mellitus in children. J Diabetes Res. 2022:59535622022. View Article : Google Scholar : PubMed/NCBI | |
Rak K and Bronkowska M: Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of type 1 diabetes mellitus-A narrative review. Molecules. 24:532018. View Article : Google Scholar : PubMed/NCBI | |
Roep BO: The role of T-cells in the pathogenesis of type 1 diabetes: From cause to cure. Diabetologia. 46:305–321. 2003. View Article : Google Scholar : PubMed/NCBI | |
Felício KM, de Souza ACCB, Neto JFA, de Melo FTC, Carvalho CT, Arbage TP, de Rider Brito HA, Peixoto AS, de Oliveira AF, de Souza Resende F, et al: Glycemic variability and insulin needs in patients with type 1 diabetes mellitus supplemented with vitamin D: A pilot study using continuous glucose monitoring system. Curr Diabetes Rev. 14:395–403. 2018. View Article : Google Scholar | |
Treiber G, Prietl B, Fröhlich-Reiterer E, Lechner E, Ribitsch A, Fritsch M, Rami-Merhar B, Steigleder-Schweiger C, Graninger W, Borkenstein M and Pieber TR: Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus-A randomized clinical trial. Clin Immunol. 161:217–224. 2015. View Article : Google Scholar : PubMed/NCBI | |
Giri D, Pintus D, Burnside G, Ghatak A, Mehta F, Paul P and Senniappan S: Treating vitamin D deficiency in children with type I diabetes could improve their glycaemic control. BMC Res Notes. 10:4652017. View Article : Google Scholar : PubMed/NCBI | |
Janyga S, Marek B, Kajdaniuk D, Ogrodowczyk-Bobik M, Urbanek A and Bułdak Ł: CD4+ cells in autoimmune thyroid disease. Endokrynol Pol. 72:572–583. 2021. View Article : Google Scholar : PubMed/NCBI | |
Chahardoli R, Saboor-Yaraghi AA, Amouzegar A, Khalili D, Vakili AZ and Azizi F: Can supplementation with vitamin D modify thyroid autoantibodies (Anti-TPO Ab, Anti-Tg Ab) and thyroid profile (T3, T4, TSH) in hashimoto's thyroiditis? A double blind, randomized clinical trial. Horm Metab Res. 51:296–301. 2019. View Article : Google Scholar : PubMed/NCBI | |
Penna-Martinez M, Filmann N, Bogdanou D, Shoghi F, Huenecke S, Schubert R, Herrmann E, Koehl U, Husebye ES and Badenhoop K: High-dose vitamin D in Addison's disease regulates T-cells and monocytes: A pilot trial. Nutrition. 49:66–73. 2018. View Article : Google Scholar : PubMed/NCBI | |
Lynde CW, Poulin Y, Vender R, Bourcier M and Khalil S: Interleukin 17A: Toward a new understanding of psoriasis pathogenesis. J Am Acad Dermatol. 71:141–150. 2014. View Article : Google Scholar : PubMed/NCBI | |
Kjær TN, Thorsen K, Jessen N, Stenderup K and Pedersen SB: Resveratrol ameliorates imiquimod-induced psoriasis-like skin inflammation in mice. PLoS One. 10:e01265992015. View Article : Google Scholar : PubMed/NCBI | |
Navegantes KC, de Souza Gomes R, Pereira PAT, Czaikoski PG, Azevedo CHM and Monteiro MC: Immune modulation of some autoimmune diseases: The critical role of macrophages and neutrophils in the innate and adaptive immunity. J Transl Med. 15:362017. View Article : Google Scholar : PubMed/NCBI | |
Balato A, Schiattarella M, Lembo S, Mattii M, Prevete N, Balato N and Ayala F: Interleukin-1 family members are enhanced in psoriasis and suppressed by vitamin D and retinoic acid. Arch Dermatol Res. 305:255–262. 2013. View Article : Google Scholar : PubMed/NCBI | |
Prtina A, Rašeta Simović N, Milivojac T, Vujnić M, Grabež M, Djuric D, Stojiljković MP, Soldat Stanković V, Čolić MJ and Škrbić R: The effect of three-month vitamin D supplementation on the levels of homocysteine metabolism markers and inflammatory cytokines in sera of psoriatic patients. Biomolecules. 11:18652021. View Article : Google Scholar : PubMed/NCBI | |
Brożyna AA, Slominski RM, Nedoszytko B, Zmijewski MA and Slominski AT: Vitamin D signaling in psoriasis: Pathogenesis and therapy. Int J Mol Sci. 23:85752022. View Article : Google Scholar | |
Weyand CM and Goronzy JJ: The immunology of rheumatoid arthritis. Nat Immunol. 22:10–18. 2021. View Article : Google Scholar : | |
van Hamburg JP, Asmawidjaja PS, Davelaar N, Mus AMC, Cornelissen F, van Leeuwen JPTM, Hazes JM, Dolhain RJ, Bakx PA, Colin EM and Lubberts E: TNF blockade requires 1,25(OH)2D3 to control human Th17-mediated synovial inflammation. Ann Rheum Dis. 71:606–612. 2012. View Article : Google Scholar : PubMed/NCBI | |
Jeffery LE, Qureshi OS, Gardner D, Hou TZ, Briggs Z, Soskic B, Baker J, Raza K and Sansom DM: Vitamin D antagonises the suppressive effect of inflammatory cytokines on CTLA-4 expression and regulatory function. PLoS One. 10:e01315392015. View Article : Google Scholar : PubMed/NCBI | |
Guan Y, Hao Y, Guan Y, Bu H and Wang H: The effect of vitamin D supplementation on rheumatoid arthritis patients: A systematic review and meta-analysis. Front Med (Lausanne). 7:5960072020. View Article : Google Scholar : PubMed/NCBI | |
Nguyen Y, Sigaux J, Letarouilly JG, Sanchez P, Czernichow S, Flipo RM, Soubrier M, Semerano L, Seror R, Sellam J and Daïen C: Efficacy of oral vitamin supplementation in inflammatory rheumatic disorders: A systematic review and meta-analysis of randomized controlled trials. Nutrients. 13:1072020. View Article : Google Scholar | |
Pan L, Lu MP, Wang JH, Xu M and Yang SR: Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr. 16:19–30. 2020. View Article : Google Scholar : | |
Berthelot JM, Le Goff B, Neel A, Maugars Y and Hamidou M: NETosis: At the crossroads of rheumatoid arthritis, lupus, and vasculitis. Joint Bone Spine. 84:255–262. 2017. View Article : Google Scholar | |
Shan J, Jin H and Xu Y: T cell metabolism: A new perspective on Th17/Treg cell imbalance in systemic lupus erythematosus. Front Immunol. 11:10272020. View Article : Google Scholar : PubMed/NCBI | |
Terrier B, Derian N, Schoindre Y, Chaara W, Geri G, Zahr N, Mariampillai K, Rosenzwajg M, Carpentier W, Musset L, et al: Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res Ther. 14:R2212012. View Article : Google Scholar : PubMed/NCBI | |
Petri M, Bello KJ, Fang H and Magder LS: Vitamin D in systemic lupus erythematosus: Modest association with disease activity and the urine protein-to-creatinine ratio. Arthritis Rheum. 65:1865–1871. 2013. View Article : Google Scholar : PubMed/NCBI | |
Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Berriotxoa A and Aguirre C: Vitamin D deficiency in systemic lupus erythematosus: Prevalence, predictors and clinical consequences. Rheumatology (Oxford). 47:920–923. 2008. View Article : Google Scholar : PubMed/NCBI | |
Lima GL, Paupitz J, Aikawa NE, Takayama L, Bonfa E and Pereira RMR: Vitamin D supplementation in adolescents and young adults with juvenile systemic lupus erythematosus for improvement in disease activity and fatigue scores: A randomized, double-blind, placebo-controlled trial. Arthritis Care Res (Hoboken). 68:91–98. 2016. View Article : Google Scholar | |
Galoppin M, Kari S, Soldati S, Pal A, Rival M, Engelhardt B, Astier A and Thouvenot E: Full spectrum of vitamin D immunomodulation in multiple sclerosis: Mechanisms and therapeutic implications. Brain Commun. 4:fcac1712022. View Article : Google Scholar : PubMed/NCBI | |
Peelen E, Muris AH, Damoiseaux J, Knippenberg S, Broens K, Smolders J, Cohen Tervaert JW, Hupperts R and Thewissen M: GM-CSF production by CD4+ T cells in MS patients: Regulation by regulatory T cells and vitamin D. J Neuroimmunol. 280:36–42. 2015. View Article : Google Scholar : PubMed/NCBI | |
Soilu-Hänninen M, Aivo J, Lindström BM, Elovaara I, Sumelahti ML, Färkkilä M, Tienari P, Atula S, Sarasoja T, Herrala L, et al: A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 83:565–571. 2012. View Article : Google Scholar | |
Feige J, Moser T, Bieler L, Schwenker K, Hauer L and Sellner J: Vitamin D supplementation in multiple sclerosis: A critical analysis of potentials and threats. Nutrients. 12:7832020. View Article : Google Scholar : PubMed/NCBI | |
Piantoni S, Andreoli L, Scarsi M, Zanola A, Dall'Ara F, Pizzorni C, Cutolo M, Airò P and Tincani A: Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin D. Lupus. 24:490–498. 2015. View Article : Google Scholar : PubMed/NCBI | |
Kello N and Cho YM: Natural supplements in antiphospholipid syndrome: A case for further study. Clin Immunol. 258:1098482024. View Article : Google Scholar | |
Agmon-Levin N, Blank M, Zandman-Goddard G, Orbach H, Meroni PL, Tincani A, Doria A, Cervera R, Miesbach W, Stojanovich L, et al: Vitamin D: An instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression. Ann Rheum Dis. 70:145–150. 2011. View Article : Google Scholar | |
Beer TM, Venner PM, Ryan CW, Petrylak DP, Chatta G, Dean Ruether J, Chi KN, Curd JG and DeLoughery TG: High dose calcitriol may reduce thrombosis in cancer patients. Br J Haematol. 135:392–394. 2006. View Article : Google Scholar : PubMed/NCBI | |
Keaney JF Jr and Rosen CJ: VITAL signs for dietary supplementation to prevent cancer and heart disease. N Engl J Med. 380:91–93. 2019. View Article : Google Scholar | |
Cannegieter SC, Doggen CJ, van Houwelingen HC and Rosendaal FR: Travel-related venous thrombosis: Results from a large population-based case control study (MEGA study). PLoS Med. 3:e3072006. View Article : Google Scholar : PubMed/NCBI | |
Cohen H, Cuadrado MJ, Erkan D, Duarte-Garcia A, Isenberg DA, Knight JS, Ortel TL, Rahman A, Salmon JE, Tektonidou MG, et al: 16th International congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends. Lupus. 29:1571–1593. 2020. View Article : Google Scholar : PubMed/NCBI | |
Ruiz-Irastorza G, Crowther M, Branch W and Khamashta MA: Antiphospholipid syndrome. Lancet. 376:1498–1509. 2010. View Article : Google Scholar : PubMed/NCBI | |
Chighizola CB, Ubiali T and Meroni PL: Treatment of thrombotic antiphospholipid syndrome: The rationale of current management-an insight into future approaches. J Immunol Res. 2015:9514242015. View Article : Google Scholar : PubMed/NCBI | |
Uludag G, Onghanseng N, Tran ANT, Hassan M, Halim MS, Sepah YJ, Do DV and Nguyen QD: Current concepts in the diagnosis and management of antiphospholipid syndrome and ocular manifestations. J Ophthalmic Inflamm Infect. 11:112021. View Article : Google Scholar : PubMed/NCBI | |
García-Carrasco M, Jiménez-Herrera EA, Gálvez-Romero JL, Mendoza-Pinto C, Méndez-Martínez S, Etchegaray-Morales I, Munguía-Realpozo P, Vázquez de Lara-Cisneros L, Santa Cruz FJ and Cervera R: The anti-thrombotic effects of vitamin D and their possible relationship with antiphospholipid syndrome. Lupus. 27:2181–2189. 2018. View Article : Google Scholar : PubMed/NCBI | |
Ota K, Dambaeva S, Han AR, Beaman K, Gilman-Sachs A and Kwak-Kim J: Vitamin D deficiency may be a risk factor for recurrent pregnancy losses by increasing cellular immunity and autoimmunity. Hum Reprod. 29:208–219. 2014. View Article : Google Scholar | |
Chen X, Yin B, Lian RC, Zhang T, Zhang HZ, Diao LH, Li YY, Huang CY, Liang DS and Zeng Y: Modulatory effects of vitamin D on peripheral cellular immunity in patients with recurrent miscarriage. Am J Reprod Immunol. 76:432–438. 2016. View Article : Google Scholar : PubMed/NCBI | |
Jeffery LE, Burke F, Mura M, Zheng Y, Qureshi OS, Hewison M, Walker LS, Lammas DA, Raza K and Sansom DM: 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol. 183:5458–5467. 2009. View Article : Google Scholar : PubMed/NCBI | |
Rafiee M, Gharagozloo M, Ghahiri A, Mehrabian F, Maracy MR, Kouhpayeh S, Pieper IL and Rezaei A: Altered Th17/Treg ratio in recurrent miscarriage after treatment with paternal lymphocytes and vitamin D3: A double-blind placebo-controlled study. Iran J Immunol. 12:252–262. 2015.PubMed/NCBI | |
Ji J, Zhai H, Zhou H, Song S, Mor G and Liao A: The role and mechanism of vitamin D-mediated regulation of Treg/Th17 balance in recurrent pregnancy loss. Am J Reprod Immunol. 81:e131122019. View Article : Google Scholar : PubMed/NCBI | |
Piantoni S, Andreoli L, Allegri F, Meroni PL and Tincani A: Low levels of vitamin D are common in primary antiphospholipid syndrome with thrombotic disease. Reumatismo. 64:307–313. 2012. View Article : Google Scholar : PubMed/NCBI | |
Bećarević M, Sarić M, Stojanovich L, Mirković D, Dopsaj V and Ignjatović S: Anti-annexin A5 antibodies and 25-hydroxycholecalciferol in female patients with primary antiphospholipid syndrome. Clin Rheumatol. 37:3359–3364. 2018. View Article : Google Scholar | |
Hanley DA, Cranney A, Jones G, Whiting SJ, Leslie WD, Cole DE, Atkinson SA, Josse RG, Feldman S, Kline GA, et al: Vitamin D in adult health and disease: A review and guideline statement from Osteoporosis Canada. CMAJ. 182:E610–E618. 2010. View Article : Google Scholar : PubMed/NCBI | |
Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, et al: The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. J Clin Endocrinol Metab. 96:53–58. 2011. View Article : Google Scholar : | |
Marcinowska-Suchowierska E, Kupisz-Urbańska M, Łukaszkiewicz J, Płudowski P and Jones G: Vitamin D toxicity-A clinical perspective. Front Endocrinol (Lausanne). 9:5502018. View Article : Google Scholar : PubMed/NCBI | |
Rolf L, Muris AH, Bol Y, Damoiseaux J, Smolders J and Hupperts R: Vitamin D3 supplementation in multiple sclerosis: Symptoms and biomarkers of depression. J Neurol Sci. 378:30–35. 2017. View Article : Google Scholar : PubMed/NCBI | |
Alkundi A, Momoh R, Musa A and Nwafor N: Vitamin D intoxication and severe hypercalcaemia complicating nutritional supplements misuse. BMJ Case Rep. 15:e2505532022. View Article : Google Scholar : PubMed/NCBI | |
Fragoso YD, Adoni T, Damasceno A, de Albuquerque Damasceno CA, Ferreira ML, Finkelzstejn A, Gomes S, Goncalves MV, Grzesiuk AK, Lins S, et al: Unfavorable outcomes during treatment of multiple sclerosis with high doses of vitamin D. J Neurol Sci. 346:341–342. 2014. View Article : Google Scholar : PubMed/NCBI | |
De Vincentis S, Russo A, Milazzo M, Lonardo A, De Santis MC, Rochira V, Simoni M and Madeo B: How much vitamin D is too much? A case report and review of the literature. Endocr Metab Immune Disord Drug Targets. 21:1653–1659. 2021. View Article : Google Scholar | |
Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D and Nicholson GC: Annual high-dose oral vitamin D and falls and fractures in older women: A randomized controlled trial. JAMA. 303:1815–1822. 2010. View Article : Google Scholar : PubMed/NCBI | |
Smith H, Anderson F, Raphael H, Maslin P, Crozier S and Cooper C: Effect of annual intramuscular vitamin D on fracture risk in elderly men and women-a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford). 46:1852–1857. 2007. View Article : Google Scholar : PubMed/NCBI | |
Rocha PN, Santos CS, Avila MO, Neves CL and Bahiense-Oliveira M: Hypercalcemia and acute kidney injury caused by abuse of a parenteral veterinary compound containing vitamins A, D, and E. J Bras Nefrol. 33:467–471. 2011. View Article : Google Scholar : PubMed/NCBI | |
Bischoff-Ferrari HA, Dawson-Hughes B, Orav EJ, Staehelin HB, Meyer OW, Theiler R, Dick W, Willett WC and Egli A: Monthly high-dose vitamin D treatment for the prevention of functional decline: A randomized clinical trial. JAMA Intern Med. 176:175–183. 2016. View Article : Google Scholar : PubMed/NCBI | |
Benemei S, Gallo E, Giocaliere E, Bartolucci G, Menniti-Ippolito F, Firenzuoli F, Mugelli A and Vannacci A: It's time for new rules on vitamin D food supplements. Br J Clin Pharmacol. 76:825–826. 2013. View Article : Google Scholar : PubMed/NCBI | |
Kimball S and Vieth R: Self-prescribed high-dose vitamin D3: Effects on biochemical parameters in two men. Ann Clin Biochem. 45:106–110. 2008. View Article : Google Scholar : PubMed/NCBI |